As control antibodies, the (h) preimmune serum from the rabbit, used for the anti-Me-R17-H3 antibody production, and (i) anti-Gal4DBD, used as an irrelevant antibody, were also used. Immunoprecitated chromatin was analyzed by quantitative PCR in the proximal pS2 promoter region (nt Ϫ159 to nt Ϫ463) [34] . (C) PCR analysis on input chromatin with the pS2 primers confirmed that equal chromatin amounts were used for ChIPs shown in (B). (D) To determine if the events described in (B) are specific to an estrogen-responsive gene, (b) anti-Me-R17-H3 immunoprecipitates were additionally analyzed for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter as a non-estrogen-regulated promoter by quantitative PCR. The GAPDH primers are specific for the CpG island region [35] . (a) PCR analysis with the GAPDH primers on input chromatin confirmed that equal chromatin amounts were used for ChIPs.
independently acting or whether they are interdepenby CARM1. Acetylation of histone H3 by CBP stimulates the tight association of CARM1 with chromatin and dent [13, 18, 22-24]. Evidence for a relationship between modifications comes from the negative interference of methylation of R17 in vivo. Recombinant CARM1 binds and methylates H3 more efficiently when H3 is acet-K9 H3 methylation by S10 H3 phosphorylation and the stimulation of K14 H3 acetylation by S10 H3 phosphoryylated, which provides a mechanism for the observed cooperativity in vivo. lation [22] [23] [24] [25] . Moreover, histone H4-R3 methylation facilitates p300-mediated acetylation [13], whereas H4 acetylation inhibits methylation by PRMT1. Although Results these results suggest the existence of an interplay between histone modifications during transcription, the Acetylation of Lysine 18 in Histone H3 Appears before Arginine 17 Methylation during existence of such crosstalk between acetylation and arginine methylation has not yet been established in vivo.
Estrogen-Regulated Transcription
We used chromatin immunoprecipitation (ChIP) analysis In this report, we show an ordered recruitment of lysine acetyltransferase and arginine methyltransferase to monitor the acetylation and methylation events that occur on the endogenous pS2 gene ( Figure 1A ) following activities in vivo on the pS2 promoter, a process that correlates closely with trancriptional activation. K18-H3 estrogen stimulation for 15, 30, 60, and 180 min ( Figure  1B) . At the same time points, the mRNA expression from acetylation by CBP/p300 precedes R17-H3 methylation Figures 1Ba, 1Bb,  1Bc, 1Bf, and 1Bg, lanes 3-8) . These estrogen-stimuCollectively, the in vivo analysis of the pS2 promoter suggests that H3 acetylation by CBP augments methylalated events on the chromatin correlate closely with higher levels of pS2 gene expression (Figure 2 , lanes tion at R17 by CARM1. To provide direct evidence that acetylation leads to increased methylation, we asked if 3-11).
We next examined whether the stimulating effect of prior acetylation of histone H3 by p300 would augment the methylation capacity of CARM1. Figure 3A shows CBP was dependent on its acetylase activity. Figure  1B shows that, when a CBP mutant compromised in that, indeed, p300-acetylated H3 acts as a better substrate for CARM1, as suggested by the results of Xu et acetylase activity (CBPmut) is transfected, a further stable chromatin association of CARM1 is not observed al. [27] . We observed a distinct migration of histone H3 in the presence of p300 that was presumably due to a (compare lanes 8 and 9, panel [a] Figure 1) , we sought to determine which of the CBP/p300 acetylation with CBP wild-type (Figure 2, compare lanes 8 and  9) . The inability of the CBPmut protein to induce these tion sites was important in stimulating CARM1 activity. We therefore synthesized H3 tail peptides that were events is not due to its inability to bind chromatin since it is associated with the promoter as efficiently as wildacetylated at either K14, K18, or K23, each of which are targets for CBP/p300 [28] , and then asked if these type CBP (panel [b], lanes 8 and 9) . We note that the CBPmut does not induce a dominant-negative effect, acetylated peptides would act as a better substrate for CARM1 methyltransferase activity. Figure 3B shows that suggesting that CBPmut is not in a large excess compared to endogenous CBP. All of the changes in R17 prior acetylation of K18, and to a lesser extent K23, increases the ability of CARM1 to methylate the H3 tail methylation observed on the pS2 promoter are specific, since methylation of R17-H3 on the active GAPDH gene peptide, whereas acetylation of K14 has a very modest effect compared to the unmodified H3 tail. The substanis not modulated either by estrogen or CBP overexpression ( Figure 2D) . tial augmentation of CARM1 activity by K18 acetylation fits well with the in vivo data in Figure 1 showing that involves increasing CARM1 interaction with its substrate. acetylation of K18 appears prior to methylation of R17 on the pS2 promoter. These in vitro data provide a mechanistic explanation for the ordered appearance of these Discussion modifications in vivo.
Acetylation of H3 may increase the enzymatic activity
The results presented here demonstrate that activation of the pS2 promoter by estrogen involves the specific of the CARM1 methyltransferase by increasing the affinity of CARM1 for its substrate. To test this, we asked if ordered deposition of distinct modifications on histone H3. Figure 5 summarizes these events. Under noninrecombinant GST-CARM1 can bind the H3 tail more effectively when H3 is acetylated. Figure 4 shows that duced conditions, the pS2 promoter is acetylated at K14, but not at the other CBP/p300 target sites, K18 or GST-CARM1 binding to unmodified H3 peptide or to a peptide acetylated at K14 is undetectable (compare K23 [28] . In addition, acetylation at K9 does not seem to play a role in the regulation of this promoter by estrogen, lanes 2 and 3 to lane 1). In contrast, acetylation of K18 (Figure 4, lane 4) or K23 (lane 8) allows GST-CARM1 to since this site is not acetylated either before or after estrogen addition. bind the H3 tail. In each of these cases, the acetyl-lysine contributes to the affinity of CARM1, since K18-and Stimulation by estrogen (or transfection of CBP) results in the association of CBP and subsequently K23-acetylated peptides (but not an unmodified peptide) can compete for the binding of CARM1 (Figure 4 , CARM1 to the chromatin. The interaction with chromatin is unlikely to be the sole mechanism by which these lanes 5, 6, and 7 and lanes 9, 10, and 11). These results indicate that, at least partly, the mechanism by which enzymes are tethered to the promoter. Both CBP and CARM1 have been shown to associate with promoteracetylation of H3 augments CARM1 enzymatic activity Under noninduced conditions, the pS2 promoter is acetylated at K14, but not at the other CBP/p300 target sites, K18 or K23. Stimulation by estrogen (or transfection of CBP) results in the association of CBP and subsequently CARM1 to the chromatin. Acetylation of K18 (after 15 min) precedes the recruitment of CARM1 and methylation at R17 and also acetylation of K23 (after 30 min). K18 acetylation seems to increase the affinity of CARM1 for its substrate, which leads to better methyltransferase activity on R17. The appearance of K23 acetylation could also be necessary to increase and strengthen the association of CARM1 with the histone H3 tail. p160 [16, 19, 29] ; so, the nent of the estrogen pathway (CBP) can switch on transcription in the absence of estrogen (Figure 2 , lanes 1 tethering to chromatin is likely to be a subsequent step that is necessary for the enzymatic activity to become and 2) indicates that components downstream of CBP necessary for estrogen-stimulated expression of pS2 manifest. In other words, binding of CBP and CARM1 to their substrate is necessary for the enzymatic activity, are not limiting. Such deregulated gene expression may be relevant in certain cancers in which components of and that crosslinking captures the enzyme-substrate interaction during activation of transcription.
bound ER and its coactivator
this pathway are overexpressed [30] . The ordered deposition of modifications is a mechaAcetylation of K18 precedes the recruitment of CARM1 and methylation at R17 (Figure 5) . Given that nism that may be employed to allow greater selectivity of gene expression. There are certain general remarks K18 acetylation allows CARM1 to associate with histone H3 tails and methylate them more effectively, the acetthat can be made regarding the events we see at the pS2 promoter that may be applicable to many other ylation of K18 by CBP may be a prerequisite for downstream CARM1 function. This argument is further genes whose activity is under the control of an external stimulus. The first thing to say is that not all modificasupported by CBP transfection experiments, which demonstrate that CARM1 association with chromatin, tions that are possible on H3 are under the control of the stimulus: acetylation of K14 is present before estrogen and methylation at R17, are not increased if the transfected CBP is unable to acetylate histone H3. Together, addition and is not regulated by it. At the same time, acetylation at K9 is not present either before or after these results provide a temporal recruitment and direct dependence of arginine methylation on prior lysine acetstimulation. There is, however, a specific set of modifications (Ac-K18, Ac-K23, and Me-R17) that is under the ylation, which explains at least in part their cooperativity in transcriptional activation.
control of the stimulus, and these modifications seem to be deposited in a specific order. This order may genInterestingly, our results show a dependency of these events on the HAT activity of p300/CBP and present erate a unique environment on the chromatin, which allows the recognition of specific proteins or results in a different picture than the one observed by Lee and collaborators [17] in which they examined the cooperathe stimulation of certain enzymatic activities. Thus, the pS2 gene may have a unique modification pattern on H3 tive effect of the acetyltransferases P/CAF and p300 with CARM1 in transient transfections. They observe (as well as other histones), which dictates its chromatin state and its gene expression pattern. that P/CAF cooperates with CARM1 in a HAT-dependent manner, whereas p300 does not. The major site for
The above concept, of specific modifications induced by estrogen for the purposes of a coordinated regulation P/CAF acetylation is K14 on histone H3, whose acetylation levels do not change during estrogen stimulation of a subset of genes, could be applied to any signaling pathway. If this would turn out to be the case, the detecof the pS2 gene (Figure 1Be) . We cannot exclude the possibility that K14 acetylation plays some role in R17 tion of histone modification patterns on specific groups of genes may be a useful means of detecting changes methylation by CARM1, but, if it is the case, it appears to be independent of the mechanism involving K18 and during differentiation, development, and the transition of normal cells into the cancerous state. moter. The fact that overexpression of a single compo-
